Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Terminal neuron localization to the upper cortical plate is controlled by the transcription factor NEUROD2.

Guzelsoy G, Akkaya C, Atak D, Dunn CD, Kabakcioglu A, Ozlu N, Ince-Dunn G.

Sci Rep. 2019 Dec 23;9(1):19697. doi: 10.1038/s41598-019-56171-x.

2.

DNA repair gene OGG1 polymorphism and its relation with oxidative DNA damage in patients with Alzheimer's disease.

Dinçer Y, Akkaya Ç, Mutlu T, Yavuzer S, Erkol G, Bozluolcay M, Guven M.

Neurosci Lett. 2019 Sep 14;709:134362. doi: 10.1016/j.neulet.2019.134362. Epub 2019 Jul 9.

PMID:
31299287
3.

[Reliability and Validity Study of the Turkish Version of Hypomania Checklist-32-Revised].

Vahip S, Aydemir Ö, Akkaya C, Altınbaş K, Kora K, Sücüllüoğlu Dikici D, Akdeniz F, Kalaycı F, Oral T, Vahip I, Alkan M, Angst J.

Turk Psikiyatri Derg. 2017 Summer;28(2):117-123. Turkish.

4.

DNA damage, DNA susceptibility to oxidation and glutathione redox status in patients with Alzheimer's disease treated with and without memantine.

Akkaya Ç, Yavuzer SS, Yavuzer H, Erkol G, Bozluolcay M, Dinçer Y.

J Neurol Sci. 2017 Jul 15;378:158-162. doi: 10.1016/j.jns.2017.04.051. Epub 2017 May 2.

PMID:
28566155
5.

The Turkish Adaptation, Validity, and Reliability of the Internal States Scale.

Maçkali Z, Akkaya C, Aydemir Ö.

Noro Psikiyatr Ars. 2016 Sep;53(3):222-228. doi: 10.5152/npa.2015.8715. Epub 2016 Sep 1.

6.

NEUROD2 Regulates Stim1 Expression and Store-Operated Calcium Entry in Cortical Neurons.

Guner G, Guzelsoy G, Isleyen FS, Sahin GS, Akkaya C, Bayam E, Kotan EI, Kabakcioglu A, Ince-Dunn G.

eNeuro. 2017 Mar 9;4(1). pii: ENEURO.0255-16.2017. doi: 10.1523/ENEURO.0255-16.2017. eCollection 2017 Jan-Feb.

7.

First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.

Sarandol A, Sarandol E, Acikgoz HE, Eker SS, Akkaya C, Dirican M.

Psychiatry Clin Neurosci. 2015 Nov;69(11):699-707. doi: 10.1111/pcn.12333. Epub 2015 Aug 18.

8.

[The validity and reliability of the Brief-Hypomanic Attitudes and Positive Predictions Inventory-Turkish version].

Maçkalı Z, Tosun A, Çağin Tosun Ö, Gürsu Hariri A, Akkaya C, İyidoğan E, Süer Yalçın E.

Turk Psikiyatri Derg. 2014 Summer;25(2):124-32. Turkish.

9.

[The relationship between the duration of drug use and the bipolar disorder patients' sociodemographic and clinical characteristics].

Akkaya C, Deniz G, Cangür S, Kırlı S.

Turk Psikiyatri Derg. 2014 Summer;25(2):94-105. Turkish.

10.

Effect of facial emotion recognition on subjective psychosocial functioning in bipolar patients.

Aydemir O, Akkaya C, Uykur B, Erol A.

Acta Psychiatr Scand. 2013 May;127(5):412-3. doi: 10.1111/acps.12069. Epub 2013 Jan 20. No abstract available.

PMID:
23331124
11.

Metabolic, endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study.

Kotan Z, Ertepe B, Akkaya C, Sarandol E, Ozkaya G, Kirli S.

Ther Adv Psychopharmacol. 2011 Dec;1(6):189-96. doi: 10.1177/2045125311426896.

12.

Association of social anxiety with stigmatisation and low self-esteem in remitted bipolar patients.

Aydemir O, Akkaya C.

Acta Neuropsychiatr. 2011 Oct;23(5):224-8. doi: 10.1111/j.1601-5215.2011.00565.x. No abstract available.

PMID:
25379893
13.

Sociodemographics, clinical features, and psychiatric comorbidities of patients with psychogenic nonepileptic seizures: experience at a specialized epilepsy center in Turkey.

Bora IH, Taskapilioglu O, Seferoglu M, Kotan OV, Bican A, Ozkaya G, Akkaya C.

Seizure. 2011 Jul;20(6):458-61. doi: 10.1016/j.seizure.2011.02.007. Epub 2011 Mar 23.

14.

Reversible escitalopram-induced hypothyroidism.

Eker SS, Akkaya C, Ersoy C, Sarandol A, Kirli S.

Gen Hosp Psychiatry. 2010 Sep-Oct;32(5):559.e5-7. doi: 10.1016/j.genhosppsych.2010.01.003. Epub 2010 Apr 27.

PMID:
20851281
15.

Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

Eker SS, Kirli S, Akkaya C, Cangur S, Sarandol A.

World J Biol Psychiatry. 2009;10(4 Pt 2):400-8. doi: 10.1080/15622970903131886.

PMID:
19670086
16.

Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.

Alptekin K, Hafez J, Brook S, Akkaya C, Tzebelikos E, Ucok A, El Tallawy H, Danaci AE, Lowe W, Karayal ON.

Int Clin Psychopharmacol. 2009 Sep;24(5):229-38. doi: 10.1097/YIC.0b013e32832c2624.

PMID:
19531959
17.

Delayed diagnosis of a neuroBehçet patient with only brainstem and cerebellar atrophy: literature review.

Taskapilioglu O, Seferoglu M, Akkaya C, Hakyemez B, Yusufoglu C, Basak AN, Gundogdu A, Bora I.

J Neurol Sci. 2009 Feb 15;277(1-2):160-3. doi: 10.1016/j.jns.2008.10.003. Epub 2008 Nov 11. Review.

PMID:
19000937
18.

[Reliability and validity of the Turkish version of the Social Adaptation Self-Evaluation Scale (SASS)].

Akkaya C, Sarandöl A, Esen Danaci A, Sivrioğlu EY, Kaya E, Kirli S.

Turk Psikiyatri Derg. 2008 Fall;19(3):292-9. Turkish.

19.

The Plasmodium falciparum-induced anion channel of human erythrocytes is an ATP-release pathway.

Akkaya C, Shumilina E, Bobballa D, Brand VB, Mahmud H, Lang F, Huber SM.

Pflugers Arch. 2009 Mar;457(5):1035-47. doi: 10.1007/s00424-008-0572-8. Epub 2008 Aug 12.

PMID:
18696103
20.

Addiction to topically used cyclopentolate hydrochloride: a case report.

Akkaya C, Zorlu Kocagoz S, Sarandol A, Eker SS, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1752-3. doi: 10.1016/j.pnpbp.2008.07.003. Epub 2008 Jul 10. No abstract available.

PMID:
18674584
21.

The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.

Eker SS, Sarandol A, Akkaya C, Sivrioglu EY, Kirli S.

J Psychopharmacol. 2009 Nov;23(8):993-6. doi: 10.1177/0269881108093843. Epub 2008 Jul 17.

PMID:
18635710
22.

Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases.

Akkaya C, Kaya B, Kotan Z, Sarandol A, Ersoy C, Kirli S.

J Psychopharmacol. 2009 Aug;23(6):723-6. doi: 10.1177/0269881108091252. Epub 2008 Jun 18.

PMID:
18562408
23.

Pathological yawning in a patient with anxiety and chronic disease anaemia.

Taskapilioglu O, Akkaya C, Sarandol A, Kirli S.

J Psychopharmacol. 2009 Mar;23(2):211-3. doi: 10.1177/0269881108089812. Epub 2008 May 30.

PMID:
18515462
24.

Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study.

Kora K, Saylan M, Akkaya C, Karamustafalioglu N, Tomruk N, Yasan A, Oral T.

Prim Care Companion J Clin Psychiatry. 2008;10(2):114-9.

25.

Laryngeal dystonia in a patient with bilateral anterior cerebral artery infarction during treatment of delirium with haloperidol.

Sari A, Akkaya C, Taskapilioglu O, Erer S, Bora I.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1347-8. doi: 10.1016/j.pnpbp.2008.03.013. Epub 2008 Mar 25. No abstract available.

PMID:
18442876
26.

Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.

Eker SS, Akkaya C, Sarandol A, Cangur S, Sarandol E, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):955-61. doi: 10.1016/j.pnpbp.2007.12.029. Epub 2008 Jan 11.

PMID:
18262705
27.

Onset of multiple sclerosis following post-partum depressive and manic episodes.

Akkaya C, Kocagoz SZ, Turan OF, Taskapilioglu O, Kirli S.

Psychiatry Clin Neurosci. 2007 Dec;61(6):698-9. No abstract available.

28.

[Development of a questionnaire to assess inter-episode functioning in bipolar disorder: Bipolar Disorder Functioning Questionnaire].

Aydemir O, Eren I, Savaş H, Kalkan Oğuzhanoğlu N, Koçal N, Devrimci Ozgüven H, Akkaya C, Devrim Başterzi A, Karlidağ R, Yenilmez C, Ozerdem A, Kora K, Tamam L, Gülseren S, Oral ET, Vahip S.

Turk Psikiyatri Derg. 2007 Winter;18(4):344-52. Turkish.

29.

Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.

Treuer T, Oruc L, Loza N, El Saidi MA, Kovacs Z, Akkaya C, Gülseren S, Saylan M, Colman SA, Harrison GA.

Psychiatr Danub. 2007 Dec;19(4):282-95.

PMID:
18000479
30.

Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting.

Akkaya C, Sarandol A, Cangur S, Kirli S.

Hum Psychopharmacol. 2007 Dec;22(8):515-28.

PMID:
17868197
31.

Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.

Sarandol A, Kirli S, Akkaya C, Ocak N, Eroz E, Sarandol E.

J Psychopharmacol. 2007 Nov;21(8):857-63. Epub 2007 Aug 22.

PMID:
17715203
32.

Trends in the annual incidence rates of narcotics felons arrested over the last 30 years in metropolitan Bursa, Turkey.

Akgoz S, Akkaya C, Berkay F, Turkmen N, Kan I, Kirli S.

Tohoku J Exp Med. 2007 Jul;212(3):253-63.

33.

Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.

Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1164-9. Epub 2007 Mar 21.

PMID:
17459548
34.

Urticaria and angio-oedema due to ziprasidone.

Akkaya C, Sarandol A, Aydogan K, Kirli S.

J Psychopharmacol. 2007 Jul;21(5):550-2. Epub 2007 Apr 19.

PMID:
17446198
35.

Artemisinin inhibits cation currents in malaria-infected human erythrocytes.

Duranton C, Akkaya C, Brand VB, Tanneur V, Lang F, Huber SM.

Nanomedicine. 2005 Jun;1(2):143-9.

PMID:
17292071
36.

Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition.

Sivrioglu EY, Topaloglu VC, Sarandol A, Akkaya C, Eker SS, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):548-50. Epub 2006 Nov 22.

PMID:
17123681
37.
38.
39.

A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.

Yazicioglu B, Akkaya C, Sarandol A, Akgoz S, Saygin Eker S, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1271-6. Epub 2006 Jul 3.

PMID:
16820257
40.

A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.

Akkaya C, Sarandol A, Sivrioglu EY, Kotan Z, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1535-8. Epub 2006 Jul 3.

PMID:
16820256
41.

[Difficulties in the diagnosis and treatment of major depressive disorder with comorbid anxiety symptoms].

Akkaya C.

Turk Psikiyatri Derg. 2006 Summer;17(2):139-46. Review. Turkish.

42.

Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes.

Tanneur V, Duranton C, Brand VB, Sandu CD, Akkaya C, Kasinathan RS, Gachet C, Sluyter R, Barden JA, Wiley JS, Lang F, Huber SM.

FASEB J. 2006 Jan;20(1):133-5. Epub 2005 Nov 2.

PMID:
16267125
43.

[Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder].

Eker SS, Akkaya C, Akgöz S, Sarandöl A, Kirli S.

Turk Psikiyatri Derg. 2005 Fall;16(3):153-63. Turkish.

44.

Permselectivity and pH-dependence of Plasmodium falciparum-induced anion currents in human erythrocytes.

Duranton C, Tanneur V, Brand V, Sandu CD, Akkaya C, Huber SM, Lang F.

Pflugers Arch. 2005 Aug;450(5):335-44. Epub 2005 May 21.

PMID:
15909180
45.

Organic osmolyte permeabilities of the malaria-induced anion conductances in human erythrocytes.

Duranton C, Huber SM, Tanneur V, Brand VB, Akkaya C, Shumilina EV, Sandu CD, Lang F.

J Gen Physiol. 2004 Apr;123(4):417-26.

Supplemental Content

Loading ...
Support Center